Carrier screening market projected to reach USD 11.44 billion by 2032 with CAGR of 19.76%

From GlobeNewswire: 2025-04-24 08:15:00

The Carrier Screening Market, valued at USD 2.26 billion in 2023, is projected to reach USD 11.44 billion by 2032, with a CAGR of 19.76%. Rising hereditary disorders and government support for genetic testing are driving market growth. The U.S. market, at USD 0.67 billion in 2023, is expected to grow consistently, backed by insurance and regulatory support.

Expanded carrier screening dominated the market in 2023, accounting for 61% of total market share. Targeted carrier screening is expected to expand, especially among high-risk populations. Spinal Muscular Atrophy led in medical conditions with 34% market share, while DNA sequencing technology held 57% market share in 2023.

Hospitals, capturing 66% of the market in 2023, are the main end-users. Laboratories lead due to testing capacity and infrastructure. North America dominated the market in 2023, with strong reimbursement programs and top genomics companies. Asia Pacific is expected to show significant growth from 2024 to 2032, driven by rising genetic illnesses and healthcare investments. Genetic carrier screening is experiencing a surge in adoption, thanks to public-private partnerships and educational programs targeting urban areas. Illumina, Myriad Genetics, and Invitae have all introduced new technologies to enhance screening accuracy and coverage for rare diseases. The market is set to see significant growth in the coming years.

A detailed table of contents for a comprehensive report on carrier screening includes statistics on genetic disorders incidence, prescription trends by region, and healthcare spending on carrier screening. The report also covers technological advancements, regulatory trends, and competitive landscape analysis. Companies like Illumina and Myriad Genetics are leading the way in this growing market.

For more information on genetic testing, non-invasive prenatal testing, and next-generation sequencing markets, check out related reports by SNS Insider. The company aims to provide clients with up-to-date market data and insights to navigate the rapidly changing landscape of carrier screening and genetic testing. With a focus on research methodology and industry developments, SNS Insider is a trusted source for market analysis.



Read more at GlobeNewswire: Carrier Screening Market to Hit USD 11.44 Billion by 2032,